TrialRMD open2025

Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies.

Helena Marzo-Ortega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.